Low‐Background His‐Tag‐Targeting Probes for Turn‐On Fluorescence Detection of Cell Surface Proteins and Their Binding Interactions
Small · 2025
DOI: 10.1002/smll.202411730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Pragati Kishore Prasad und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Structural Biology, Weizman Institute of Science, Rehovot, 7610001, Israel. Hauptthemen laut MEDLINE: Fluorescent Dyes, Membrane Proteins, Histidine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, Minerva Foundation.
Abstract (Originalsprache)
Turn‐on fluorescent probes consisting of dye‐ligand conjugates serve as a powerful tool for detecting cell surface proteins (CSPs) and their interactions with binding partners. However, generating such probes from protein‐based ligands remains challenging. This challenge became particularly evident during the COVID‐19 pandemic, which highlighted the need for assays to evaluate inhibitors of the interaction between the SARS‐CoV‐2 virus receptor‐binding domain (RBD) and the angiotensin‐converting enzyme 2 (ACE2) receptor. To sense this interaction in a cellular environment using turn‐on probes, a tri‐nitrilotriacetic acid (tri‐NTA) unit was conjugated to quinoline‐based cyanine (QBC) dyes. This design leverages the high affinity of tri‐NTA for His‐tag, along with the low‐background and confinement‐sensitive optical responses of QBC dyes, to create probes that fluoresce upon binding to His‐tagged proteins on cell surfaces. Herein, it is shown that this approach enables the development of an exceptionally simple cell‐based assay with which inhibitors of the RBD‐ACE2 interaction can be readily sensed by combining a turn‐on probe, His‐tagged RBD, ACE2‐expressing cells, and recording changes in the probe's emission spectra. The potential of this method is further demonstrated by using such probes to detect lectin binding to cell surface glycans and to image a bacterial CSP under wash‐free conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Structural Biology, Weizman Institute of Science, Rehovot, 7610001, Israel.
- Department of Biomolecular Sciences, Weizman Institute of Science, Rehovot, 7610001, Israel.
- Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, 7610001, Israel.
- Indian Institute of Science Education and Research, Pune, 411008, India.
ORCID-Profile: David Margulies
Förderung
- Israel Science Foundation
- Minerva Foundation
Zitieren
APA
Prasad, P. K., Toraskar, S., Khan, S., Granot, T., Sirkis, Y. F., Yardeni, E. H., Albeck, S., Unger, T., Petrovich-Kopitman, E., Addadi, Y., Raigawali, R., Anand, S., Vishweshwara, S. S., Shanthamurthy, C. D., Oppenheimer-Low, N., Kikkeri, R., Avinoam, O., Motiei, L., & Margulies, D. (2025). Low‐Background His‐Tag‐Targeting Probes for Turn‐On Fluorescence Detection of Cell Surface Proteins and Their Binding Interactions. Small. https://doi.org/10.1002/smll.202411730
Vancouver
Prasad PK, Toraskar S, Khan S, Granot T, Sirkis YF, Yardeni EH, et al. Low‐Background His‐Tag‐Targeting Probes for Turn‐On Fluorescence Detection of Cell Surface Proteins and Their Binding Interactions. Small. 2025. doi:10.1002/smll.202411730
BibTeX
@article{Prasad2025,
author = {Prasad, Pragati Kishore and Toraskar, Suraj and Khan, Suman and Granot, Tom and Sirkis, Yael Fridmann and Yardeni, Eliane Hadas and Albeck, Shira and Unger, Tamar and Petrovich-Kopitman, Ekaterina and Addadi, Yoseph and Raigawali, Rakesh and Anand, Saurabh and Vishweshwara, Sharath S and Shanthamurthy, Chethan D and Oppenheimer-Low, Noa and Kikkeri, Raghavendra and Avinoam, Ori and Motiei, Leila and Margulies, David},
title = {Low‐Background His‐Tag‐Targeting Probes for Turn‐On Fluorescence Detection of Cell Surface Proteins and Their Binding Interactions},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202411730}
}
EUVIMED